| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.4 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |